Anti-PD1 therapies induce an early expansion of Ki67+CD8+ T cells in metastatic non-oncogene addicted NSCLC patients.
Gelibter A, Tuosto L, Asquino A, Siringo M, Sabatini A, Zizzari IG, Pace A, Scirocchi F, Valentino F, Bianchini S, Caponnetto S, Paoli D, Bellati F, Santini D, Nuti M, Rughetti A, Napoletano C.
Gelibter A, et al. Among authors: sabatini a.
Front Immunol. 2024 Dec 18;15:1483182. doi: 10.3389/fimmu.2024.1483182. eCollection 2024.
Front Immunol. 2024.
PMID: 39744631
Free PMC article.